The present study aimed to examine whether the APOE ε4 allele, associated with dementia with Lewy bodies (DLB), and possibly with dementia in Parkinson's disease (PD), is also associated with idiopathic rapid eye movement sleep behavior disorder (RBD). Two single nucleotide polymorphisms, rs429358 and rs7412, were genotyped in RBD patients (n = 480) and in controls (n = 823). APOE ε4 allele frequency was 0.14 among RBD patients and 0.13 among controls (OR = 1.11, 95% CI: 0.88â1.40, p = 0.41). APOE ε4 allele frequencies were similar in those who converted to DLB (0.14) and those who converted to Parkinson's disease (0.12) or multiple system atrophy (0.14, p = 1.0). The APOE ε4 allele is neither a risk factor for RBD nor it is associated with conversion from RBD to DLB or other synucleinopathies.
The dementia-associated APOE ε4 allele is not associated with rapid eye movement sleep behavior disorder / Gan-Or, Ziv; Montplaisir, Jacques Y.; Ross, Jay P.; Poirier, Judes; Warby, Simon C.; Arnulf, Isabelle; Strong, Stephanie; Dauvilliers, Yves; Leblond, Claire S.; Michele T. M., Hu; Högl, Birgit; Stefani, Ambra; Monaca, Christelle Charley; De Cock, Valérie Cochen; Boivin, Michel; Ferini-Strambi, Luigi; Plazzi, Giuseppe; Antelmi, Elena; Young, Peter; Heidbreder, Anna; Barber, Thomas R.; Evetts, Samuel G.; Rolinski, Michal; Dion, Patrick A.; Desautels, Alex; Gagnon, Jean-François; Dupré, Nicolas; Postuma, Ronald B.; Rouleau, Guy A.. - In: NEUROBIOLOGY OF AGING. - ISSN 0197-4580. - 49:(2017), pp. 218-218.e15. [10.1016/j.neurobiolaging.2016.10.002]
The dementia-associated APOE ε4 allele is not associated with rapid eye movement sleep behavior disorder
Ferini-Strambi, Luigi;
2017-01-01
Abstract
The present study aimed to examine whether the APOE ε4 allele, associated with dementia with Lewy bodies (DLB), and possibly with dementia in Parkinson's disease (PD), is also associated with idiopathic rapid eye movement sleep behavior disorder (RBD). Two single nucleotide polymorphisms, rs429358 and rs7412, were genotyped in RBD patients (n = 480) and in controls (n = 823). APOE ε4 allele frequency was 0.14 among RBD patients and 0.13 among controls (OR = 1.11, 95% CI: 0.88â1.40, p = 0.41). APOE ε4 allele frequencies were similar in those who converted to DLB (0.14) and those who converted to Parkinson's disease (0.12) or multiple system atrophy (0.14, p = 1.0). The APOE ε4 allele is neither a risk factor for RBD nor it is associated with conversion from RBD to DLB or other synucleinopathies.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
